Influenza A virus causes both pandemic and seasonal outbreaks, leading to loss of from thousands to millions of human lives within a short time period. Vaccination is the best option to prevent and minimize the effects of influenza outbreaks. Rapid selection of a well-matched influenza vaccine strain is the key to developing an effective vaccination program. However, this is a non-trivial task due to three major challenges in influenza vaccine strain selection: labor an time intensive virus isolation and serology-based antigenic characterization, poor growth of selected strains in chicken embryonic eggs during production, and biased sampling in influenza surveillance. Each year, many scientists worldwide, including thousands from the United States, are working altogether to select an optimal vaccine strain. However, incorrect vaccine strains have still been frequently chosen in the past decades. Recent advances in genomic sequencing allow us to rapidly and economically sequence influenza genomes from the isolates and from the clinical samples. Sequencing influenza genomes has become a routine and important component in influenza surveillance. The objectives of this project are to develop a sequence-based strategy for influenza antigenic variant identification and to optimize vaccine strain selection using genomic data. To achieve these aims, we will develop machine learning based computational methods to estimate antigenic distances among influenza viruses by directly using their genome sequences. We will then identify the key residues and mutations in influenza genomes affecting influenza antigenic drift events. Such information will allow us to select most promising virus strains as candidates for vaccine production. Since economical virus production requires the selected virus strains to grow easily in chicken embryonic eggs, we also propose the development of a machine learning based method that can predict the growth ability of a virus strain based on its sequence information. This integrated genome based influenza vaccine strain selection system will be developed for detecting antigenic variants for influenza A viruses. This project will help us provide fundamental technology that employs genomic signatures determining influenza antigenicity and growth ability in chicken embryonic eggs, which are the two key issues for efficient and effective influenza vaccine strain development. The resulting genome based vaccine strain selection strategy will significantly reduce the human labor needed for serological characterization, decrease the time required to select an effective strain that will grow well in eggs, and increase the likelihood of correct influenza vaccine candidate selection. Thus, this project will lead to significant technological advances in influenza prevention and control.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI116744-05
Application #
9610628
Study Section
Genetic Variation and Evolution Study Section (GVE)
Program Officer
Gordon, Jennifer L
Project Start
2015-01-15
Project End
2019-12-31
Budget Start
2019-01-01
Budget End
2019-12-31
Support Year
5
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Mississippi State University
Department
Veterinary Sciences
Type
Schools of Veterinary Medicine
DUNS #
075461814
City
Mississippi State
State
MS
Country
United States
Zip Code
39762
Wen, Feng; Li, Lei; Zhao, Nan et al. (2018) A Y161F Hemagglutinin Substitution Increases Thermostability and Improves Yields of 2009 H1N1 Influenza A Virus in Cells. J Virol 92:
Li, Lei; Bowman, Andrew S; DeLiberto, Thomas J et al. (2018) Genetic Evidence Supports Sporadic and Independent Introductions of Subtype H5 Low-Pathogenic Avian Influenza A Viruses from Wild Birds to Domestic Poultry in North America. J Virol 92:
Kosikova, Martina; Li, Lei; Radvak, Peter et al. (2018) Imprinting of Repeated Influenza A/H3 Exposures on Antibody Quantity and Antibody Quality: Implications for Seasonal Vaccine Strain Selection and Vaccine Performance. Clin Infect Dis 67:1523-1532
Xie, Hang; Li, Lei; Ye, Zhiping et al. (2017) Differential Effects of Prior Influenza Exposures on H3N2 Cross-reactivity of Human Postvaccination Sera. Clin Infect Dis 65:259-267
Martin, Brigitte E; Bowman, Andrew S; Li, Lei et al. (2017) Detection of Antigenic Variants of Subtype H3 Swine Influenza A Viruses from Clinical Samples. J Clin Microbiol 55:1037-1045
Wu, Zhigang; Liu, Yunpeng; Li, Lei et al. (2017) Decoding glycan protein interactions by a new class of asymmetric N-glycans. Org Biomol Chem 15:8946-8951
Han, Lei; Zhang, Yu; Zhang, Tong (2016) Fast Component Pursuit for Large-Scale Inverse Covariance Estimation. KDD 2016:1585-1594
Bailey, Elizabeth; Long, Li-Ping; Zhao, Nan et al. (2016) Antigenic Characterization of H3 Subtypes of Avian Influenza A Viruses from North America. Avian Dis 60:346-53
Li, Yin; Huang, Xin-Mei; Zhao, Dong-Min et al. (2016) Detection of Avian H7N9 Influenza A Viruses in the Yangtze Delta Region of China During Early H7N9 Outbreaks. Avian Dis 60:118-25
Xu, Yifei; Bailey, Elizabeth; Spackman, Erica et al. (2016) Limited Antigenic Diversity in Contemporary H7 Avian-Origin Influenza A Viruses from North America. Sci Rep 6:20688

Showing the most recent 10 out of 14 publications